Manufacturers Life Insurance Company, The Centessa Pharmaceuticals PLC Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 264,969 shares of CNTA stock, worth $4.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
264,969
Previous 140,894
88.06%
Holding current value
$4.55 Million
Previous $1.27 Million
233.02%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$343 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$171 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$166 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$108 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$102 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.62B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...